Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4528 |  ABVC ABVC BioPharma, Inc. - Common Stock | 0.91 USD | +2.25% | +3.41% | -20.87% | -72.51% | 24.26 M USD | ||
| 4531 |  ENLV Enlivex Ltd. - Ordinary Shares | 1.50 USD | +2.04% | -4.46% | -64.95% | +40.19% | 23.74 M USD | ||
| 4533 |  MRKR Marker Therapeutics, Inc. - Common Stock | 1.52 USD | +9.35% | +29.91% | +25.62% | +17.83% | 25.34 M USD | ||
| 4534 |  CELU Celularity Inc. - Class A Common Stock | 0.77 USD | -3.75% | +10.00% | -3.75% | -79.95% | 22.29 M USD | ||
| 4544 |  ALLR Allarity Therapeutics, Inc. - Common stock | 1.39 USD | -2.11% | +1.46% | +16.81% | +49.46% | 22.12 M USD | ||
| 4546 |  COCP Cocrystal Pharma, Inc. - Common Stock | 1.12 USD | -2.61% | -1.75% | +23.08% | -28.21% | 21.57 M USD | ||
| 4554 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.25 USD | -1.19% | -1.19% | +4.66% | +126.50% | 21.45 M USD | ||
| 4561 |  NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.90 USD | -0.26% | +1.56% | +4.56% | -46.06% | 21.08 M USD | ||
| 4583 |  PLUR Pluri Inc. - Common Stock | 1.70 USD | -7.61% | +1.80% | -5.03% | -55.50% | 18.34 M USD | ||
| 4592 |  CALC CalciMedica, Inc. - Common Stock | 0.56 USD | -1.75% | -18.84% | -24.32% | -80.00% | 19.12 M USD | ||
| 4594 |  RADX Radiopharm Theranostics Limited American Depositary Shares | 2.47 USD | +1.23% | -3.52% | -28.20% | -57.85% | 19.47 M USD | ||
| 4608 |  CYCN Cyclerion Therapeutics, Inc. - Common Stock | 4.10 USD | +4.06% | +5.13% | +20.23% | +65.32% | 19.19 M USD | ||
| 4617 |  LEXX Lexaria Bioscience Corp. - Common Stock | 10.42 USD | -4.58% | +11.32% | +1794.55% | +1186.42% | 17.22 M USD | ||
| 4632 |  PTN Palatin Technologies, Inc. Common Stock | 10.14 USD | +4.64% | +4.43% | +31.35% | +39.86% | 18.04 M USD | ||
| 4635 |  LPCN Lipocine Inc. - Common Stock | 2.07 USD | 0.00% | 0.00% | -0.96% | -28.62% | 17.07 M USD | ||
| 4648 |  CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.59 USD | -1.67% | +3.51% | +18.00% | -55.97% | 16.20 M USD | ||
| 4651 |  ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 USD | -15.59% | +25.30% | +91.61% | +1281.58% | 13.79 M USD | ||
| 4653 |  KALA KALA BIO, Inc. - Common Stock | 0.80 USD | -4.76% | -12.09% | +29.03% | -91.26% | 15.47 M USD | ||
| 4656 |  HIND Vyome Holdings, Inc. - Common Stock | 2.29 USD | +0.44% | +5.05% | +11.17% | -80.19% | 16.07 M USD | ||
| 4662 |  INTS Intensity Therapeutics, Inc. - Common Stock | 4.71 USD | -3.09% | +16.30% | +4.67% | +1470.00% | 15.38 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |